Hiển thị các bài đăng có nhãn linked. Hiển thị tất cả bài đăng
Hiển thị các bài đăng có nhãn linked. Hiển thị tất cả bài đăng

Thứ Năm, 23 tháng 2, 2012

Support for Tougher Liquor Laws Rises When Booze, Crime Linked

WEDNESDAY, Feb. 22 (HealthDay News) -- News coverage of alcohol's role in violent crime and fatal accidents may persuade the public to give stronger support to alcohol-control laws, new research suggests.

It is estimated that drinking is involved in nearly one-third of deaths from accidents and violent crime. Most news reports of such cases, however, make no mention of alcohol, according to the authors of the study, published in the March issue of the Journal of Studies on Alcohol and Drugs.

"People have some awareness of the social cost that alcohol can have," study author Michael D. Slater, of Ohio State University, in Columbus, said in a journal news release. "But only a small fraction of news stories on violent crime and nonmotor-vehicle accidents acknowledge the contributing role of alcohol."

This means that many people don't realize how often alcohol plays a role in violence and accidents that don't occur on the roads. This lack of awareness may dampen public support for alcohol-control laws such as strict enforcement of underage drinking rules or bans on serving alcohol to drunk customers, Slater said.

In the study, Slater and his colleagues surveyed 789 adults and found that they were more likely to support alcohol-control laws after they read media stories about violent crime, vehicle crashes and other accidents involving alcohol.

"I think this buttresses the idea that media coverage does matter," Slater said. "Alcohol, as a public-health issue, is not as front and center as it might be if there were more news coverage."

In areas that already have alcohol-control laws, public support is still important because local resources are needed to enforce those laws, he noted. Local authorities should mention any role of alcohol when giving details about crimes and accidents to the media, Slater added.

More information

The U.S. Centers for Disease Control and Prevention offers an overview of alcohol and public health.


View the original article here

'Biological clock' is linked to heart attacks

Scientists on Wednesday said they had uncovered the first molecular proof that the "biological clock" is linked to a type of sudden, fatal heart attack.

Ventricular arrhythmia, or abnormal heartbeat, occurs most frequently after waking in the morning -- and also to a lesser degree in the evening hours -- and causes a high number of deaths.

Reporting in the journal Nature, researchers in the United States said they had uncovered the first molecular link between this risk and circadian rhythm, the term by which biological processes vary according to a 24-hour period.

The finger points at levels of a protein called Klf15, they said.

Previous research has found Klf15 to be a circadian controller -- and, startlingly, is also lacking among some patients with heart failure.

The team created mice that had been genetically engineered to either lack Klf15 or make the protein excessively.

In both cases, the rodents had a much higher risk of arrythmias compared to normal counterparts.

"It is the first example of a molecular mechanism for the circadian change in susceptibility to cardiac arrhythmias," said Xander Wehrens of Baylor College School of Medicine in Houston, Texas.

"If there was too much Klf15 or none, the mice were at risk for developing the arrhythmia."

Klf15 is only one step in a complex molecular cascade, the researchers believe.

It controls another protein, KChIP2, which affects potassium-generated electrical current that flows though heart muscle cells called cardiac myocytes.

When levels of KChIP2 fluctuate, this causes electrical instability in the myocytes.

As a result, the heart muscle's action becomes impaired and it takes longer (or conversely, less time) to empty the ventricle -- the heart's pumping chamber. The heart loses the regularity of the beat and labours to pump blood efficiently.

Co-author Mukesh Jain of the Case Western Reserve University School of Medicine in Cleveland, Ohio said that further work could well uncover other circadian-related causes.

The discovery opens up intriguing paths of research, in pinpointing individuals at risk of nocturnal death and devising drugs to shield them, Jain added.


View the original article here

Thứ Sáu, 17 tháng 2, 2012

Gene Linked to Start of Puberty

WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers report that they've discovered the importance of a particular gene in kicking off puberty in humans, a finding that offers insight into how the mysterious process begins and could help children who suffer from a rare disease that prevents the start of puberty.

An analysis of the DNA of a family whose members have suffered from the disease confirmed that the gene is vital because it paves the way for the body to process a hormone known as kisspeptin.

"Without kisspeptin, a human being cannot attain sexual characteristics of his/her gender and child-bearing capacity. Kisspeptin is absolutely required for the start of the puberty process in humans," said study author Dr. A. Kemal Topaloglu, of the department of pediatric endocrinology at Cukurova University in Adana, Turkey.

A mutation in the gene, the researchers found, can cause a rare condition called hypogonadotropic hypogonadism, in which children don't fully enter puberty.

Dr. William F. Crowley Jr., director of the Harvard Reproductive Endocrine Sciences Center at Harvard Medical School, said the condition affects no more than one in 10,000 children, and perhaps even fewer.

"They look like they're 12 years old, even when they're 20. They don't have a growth spurt and tend to be short, and the males don't shave," Crowley said.

In the new study, researchers examined the genetic makeup of a family in which four daughters had the disease. They linked the disease to a mutation in the gene that creates a receptor that processes the kisspeptin hormone.

The hormone can be used to make the brain produce hormones that stimulate the maturation of ovaries and testicles, Topaloglu said. Also, medications that shut down the hormone could be used to treat a condition that causes early puberty, he said, or serve as a contraceptive.

"Such drugs can also be used in the treatment of cancers that are stimulated by sex hormones, the most notably breast and prostate cancers," Topaloglu said.

The research could lead to alternative treatments for the puberty-preventing disease. Currently, hormone therapy is almost always a success when used to treat kids with the condition, but it's more difficult to enable them to have children of their own once they grow up, Topaloglu said.

As for the big question of what causes puberty, Crowley said the new findings help provide another clue. They show how the gene -- one of 19 -- helps turn on the pilot light that powers puberty, he said.

"This is a very rare cause of a very rare condition," he said. "But every piece of this puzzle winds up being very important to putting the whole thing together."

The study appears in the Feb. 16 issue of The New England Journal of Medicine.

More information

For more about puberty and adolescence, try the U.S. National Library of Medicine.


View the original article here

Thứ Tư, 15 tháng 2, 2012

Wider Waistlines Linked to Memory Problems in HIV Patients

MONDAY, Feb. 13 (HealthDay News) -- HIV-positive patients with larger waistlines may be at greater risk for memory problems, according to a new study. Exposure to combinations of certain anti-HIV drugs could play a role in this reduced mental function, researchers said.

"Interestingly, bigger waistlines were linked to decreased mental functioning more than was general obesity," said study author Dr. J. Allen McCutchan, at the University of California, San Diego, in a journal news release. "This is important because certain anti-HIV drugs cause weight gain in the center of the body that is most dramatic in the abdomen, neck, chest and breasts."

Researchers looked at 130 HIV-positive patients who were about 46 years old and who had been infected for an average of 13 years. Most patients were on antiretroviral therapy consisting of combinations of anti-HIV drugs.

Forty percent of the participants had "neurocognitive impairment" -- reduced mental function such as poor memory and/or concentration. These patients also had a waist measuring an average of 39 inches.

In contrast, patients with normal mental function had an average waist size of 35 inches.

The study appears in the Feb. 14 issue of the journal Neurology.

"Avoiding those HIV drugs that cause larger waistlines might protect or help to reverse [mental impairment]," McCutchan said. "We don't know if central obesity is causing [the problem] directly or is just a marker for exposure to a more direct cause such as anti-HIV drugs. People with HIV should talk to their doctors before considering changes in their anti-HIV medications."

The study authors pointed out that reduced mental function was also linked to older age, a longer time living with HIV and diabetes in patients older than 55.

More information

The U.S. Centers for Disease Control and Prevention provides more information on HIV/AIDS.


View the original article here

Thứ Ba, 7 tháng 2, 2012

HIV drugs not linked with child psychiatric problems

CHICAGO (Reuters) - Drugs used to treat children infected with the virus that causes AIDS do not appear to increase the risk of psychiatric problems in children, U.S. researchers said on Monday.

Scientists have been worried about the high rates of psychiatric and academic problems in children infected with the human immunodeficiency virus, or HIV -- the virus that causes

AIDS.

"The question that is coming up is why do they have so many issues? Is it their HIV, is it their antiretrovirals or is it other factors?" said Dr. Sharon Nachman of Stony Brook University in New York, who worked on the study published in Archives of Pediatrics & Adolescent Medicine.

In an earlier study, the team found similarly high rates of psychiatric problems in children with HIV and in those who have a family member with HIV, suggesting that stresses in the environment likely play some role.

For the latest study, Nachman and colleagues looked specifically at children with HIV in an attempt to tease out some of those answers.

They analyzed data on 319 HIV-infected children and adolescents aged between 6 and 17 years who were enrolled in the International Maternal Pediatrics Adolescent AIDS Clinical Trials Group study.

A third of the children had at least one psychiatric disorder, such as depression or attention deficit hyperactivity disorder (ADHD).

The team also reviewed the children's disease history and markers of disease severity, such as their viral load -- the levels of the virus in their blood -- and measures of infection-fighting cells known as CD4 cells.

The team found no link between the HIV drugs known as antiretrovirals that the children were taking to control their disease and any psychiatric problem.

"It wasn't the antiretrovirals. It didn't matter which antiretrovirals the kids used. Those didn't predict or prevent a kid from getting a psychiatric illness" or having social or academic problems, Nachman said in a telephone interview.

When they looked at severity of the disease, as measured by how much virus was in the blood or how well the immune system was working, the results were mixed.

For example, they said children who entered the study with a lower CD4 percentage -- a reflection of the number of infection-fighting cells in the blood -- had less severe depression.

But children who had high levels of the HIV virus in their blood when they entered the study had more severe depression.

However, severity of disease did appear to play a role when it came to critical cognitive skills known as executive functioning.

The team found children who had the most severe disease when they entered the study did worse on tests of executive functioning, such as remembering a sequence of numbers, Nachman said.

"It appears if you had a high viral load at a young age or a low CD4 percentage, you did get a hit on your brain" in terms of executive functioning, Nachman said.

The study does not prove cause and effect, but Nachman said it does suggest that HIV infection could affect the brain.

Some doctors are debating about whether to treat a child who has less severe disease, Nachman said, but added that tests of the immune system or levels of the virus may not reveal the whole picture.


View the original article here